DermTech Inc

1.65-0.0500-2.94%Vol 125.71K1Y Perf -59.91%
Sep 22nd, 2023 16:00 DELAYED
BID1.61 ASK1.68
Open1.69 Previous Close1.70
Pre-Market- After-Market1.73
 - -  0.08 4.85%
Target Price
10.67 
Analyst Rating
Moderate Buy 2.00
Potential %
546.67 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-71/-89/-93 
Value Ranking
★★★★     56.24
Insiders Value % 3/6/12 mo.
71/-19/-53 
Growth Ranking
★★★★+     62.87
Insiders Shares Cnt. % 3/6/12 mo.
67/7/-14 
Income Ranking
 —    -
Price Range Ratio 52W %
2.04 
Earnings Rating
Market Cap55.57M 
Earnings Date
2nd Nov 2023
Alpha0.00 Standard Deviation0.41
Beta2.23 

Today's Price Range

1.621.69

52W Range

1.556.44

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-8.84%
1 Month
-30.38%
3 Months
-28.88%
6 Months
-49.23%
1 Year
-59.91%
3 Years
-84.76%
5 Years
-91.82%
10 Years
-

TickerPriceChg.Chg.%
DMTK1.65-0.0500-2.94
AAPL174.790.86000.49
GOOG131.25-0.1100-0.08
MSFT317.01-2.5200-0.79
XOM114.940.18000.16
WFC41.23-1.0900-2.58
JNJ160.50-1.1600-0.72
FB196.640.99000.51
GE111.25-1.7400-1.54
JPM145.73-1.4100-0.96
Financial StrengthValueIndustryS&P 500US Markets
9.10
9.50
0.12
0.15
-73.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
7.70
-787.30
-762.00
-
-
RevenueValueIndustryS&P 500US Markets
11.52M
0.38
64.59
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.95-0.99-4.21
Q01 2023-0.90-1.02-13.33
Q04 2022-0.96-0.933.12
Q03 2022-0.99-0.963.03
Q02 2022-1.02-0.992.94
Q01 2022-0.85-1.01-18.82
Q04 2021-0.73-0.88-20.55
Q03 2021-0.65-0.68-4.62
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date2nd Nov 2023
Estimated EPS Next Report-0.68
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume125.71K
Shares Outstanding33.68K
Shares Float28.69M
Trades Count704
Dollar Volume206.68K
Avg. Volume235.37K
Avg. Weekly Volume238.90K
Avg. Monthly Volume204.69K
Avg. Quarterly Volume262.52K

DermTech Inc (NASDAQ: DMTK) stock closed at 1.65 per share at the end of the most recent trading day (a -2.94% change compared to the prior day closing price) with a volume of 125.71K shares and market capitalization of 55.57M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. DermTech Inc CEO is John D Dobak.

The one-year performance of DermTech Inc stock is -59.91%, while year-to-date (YTD) performance is -6.78%. DMTK stock has a five-year performance of -91.82%. Its 52-week range is between 1.55 and 6.44, which gives DMTK stock a 52-week price range ratio of 2.04%

DermTech Inc currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 0.42, a price-to-sale (PS) ratio of 5.72, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -49.36%, a ROC of -52.51% and a ROE of -56.28%. The company’s profit margin is -%, its EBITDA margin is -762.00%, and its revenue ttm is $11.52 Million , which makes it $0.38 revenue per share.

Of the last four earnings reports from DermTech Inc, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.68 for the next earnings report. DermTech Inc’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for DermTech Inc is Moderate Buy (2), with a target price of $10.67, which is +546.67% compared to the current price. The earnings rating for DermTech Inc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DermTech Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DermTech Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 30.90, ATR14 : 0.16, CCI20 : -114.56, Chaikin Money Flow : -0.18, MACD : -0.22, Money Flow Index : 12.87, ROC : -18.72, RSI : 30.13, STOCH (14,3) : 6.43, STOCH RSI : 0.28, UO : 35.83, Williams %R : -93.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DermTech Inc in the last 12-months were: Akhavan Ramin (Sold 3 776 shares of value $9 553 ), Claudia Ibarra (Sold 12 955 shares of value $46 672 ), Dobak John (Sold 25 514 shares of value $102 340 ), Ibarra Claudia (Sold 20 519 shares of value $66 739 ), John D Dobak (Sold 25 514 shares of value $102 340 ), Kevin Sun (Sold 12 221 shares of value $48 662 ), Ramin Akhavan (Sold 17 278 shares of value $64 371 ), Sun Kevin M (Sold 8 253 shares of value $21 246 ), Todd Michael Wood (Sold 10 114 shares of value $38 999 ), Wood Todd (Sold 14 467 shares of value $50 345 ), Wood Todd Michael (Sold 5 342 shares of value $13 628 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

DermTech Inc

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

CEO: John D Dobak

Telephone: +1 858 450-4222

Address: 11099 N. Torrey Pines Road, La Jolla 92037, CA, US

Number of employees: 64

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

55%45%

 

News

Stocktwits